Transcatheter Hepatic Arterial Drug Infusion Therapy for Hepatocellular Carcinoma: Effect on the Arterial Ketone Body Ratio

References

• Yamada R, Sato M, Kawabata M. Hepatic artery embolization in 120 patients with unresectable hepatoma. Radiology 1983; 148: 397–401
   PubMed Web of Science ®Google Scholar
• Clouse M E, Lee R GL, Duszlak E J. Peripheral hepatic artery embolization for primary and secondary hepatic neoplasms. Radiology 1983; 147: 407–11
   PubMedGoogle Scholar
• Breedis C, Young G. The blood supply of neoplasms in the liver. Am J Pathol 1954; 30: 969–77
   PubMed Web of Science ®Google Scholar
• Ukikusa M, Ozawa K, Shimabara Y. Changes in blood ketone body ratio. Their significance after major hepatic resection. Arch Surg 1981; 116: 781–5
   Google Scholar
• Tanaka J, Ozawa K, Tobe T. Significance of blood ketone body ratio as an indicator of hepatic cellular energy status in jaundiced rabbits. Gastroenterology 1979; 76: 691–6
   PubMed Web of Science ®Google Scholar
• Ozawa K, Fujimoto T, Nakatani T. Changes in hepatic energy charge, blood ketone body ratio, and indocyanine green clearance in relation to DNA synthesis after hepatectomy. Life Sci 1982; 31: 647–53
   PubMedGoogle Scholar
• Mori K, Ozawa K, Yamamoto Y. Response of hepatic mitochondrial redox state to oral glucose load. Ann Surg 1990; 211: 438–46
   PubMedGoogle Scholar
• Iwata S, Ozawa K, Shimahara Y. Diurnal fluctuations of arterial ketone body ratio in normal subjects and patients with liver dysfunction. Gastroenterology 1991; 100: 1371–8
   PubMedGoogle Scholar
• Williamson D H, Mellanby J, Krebs H A. Enzymatic determination of D(-)-β-hydroxybutyric acid and acetoacetic acid in blood. Biochem J 1962; 82: 90–6
   PubMed Web of Science ®Google Scholar
• Williamson D H, Lund P, Krebs H A. The redox state of free nicotinamide adenine dinucleotide in the cytoplasm and mitochondria of rat liver. Biochem J 1967; 103: 524–7
   Google Scholar
• Atkinson D E. The energy charge of the adenylate pool as a regulatory parameter. Interaction with feedback modifiers. Biochemistry 1968; 7: 4030–4
   Google Scholar
• Kamiike W, Watanabe F, Hashimoto T. Changes in cellular levels of ATP and its catabolites in ischemic rat liver. J Biochem 1982; 91: 1349–56
   PubMed Web of Science ®Google Scholar
• Ayuso-Parrilla M S, Parrilla R. Control of hepatic protein synthesis. Differential effects of ATP levels on the initiation and elongation steps. Eur J Biochem 1975; 55: 593–9
   PubMedGoogle Scholar
• Richard A I, Barton P G, Cohen R D. The effect of reduction of perfusion rate on lactate and oxygen uptake, glucose output and energy supply in the isolated perfused liver of starved rats. Biochem J 1979; 184: 635–42
   PubMedGoogle Scholar
• Kiuchi T, Ozawa K, Yamamoto Y. Changes in arterial ketone body ratio in the phase immediately after hepatectomy. Arch Surg 1990; 125: 655–9
   PubMedGoogle Scholar
• Taki Y, Gubernatis G, Yamaoka Y. Significance of arterial ketone body ratio measurement in human liver transplantation. Transplantation 1990; 49: 535–9
   PubMed Web of Science ®Google Scholar
• Asonuma K, Takaya S, Selby R. The clinical significance of the arterial ketone body ratio as an early indicator of graft viability in human liver transplantation. Transplantation 1991; 51: 164–71
   PubMed Web of Science ®Google Scholar
• Saibara T, Onishi S, Sone J. Arterial ketone body ratio as a possible indicator for liver transplantation in fulminant hepatic failure. Transplantation 1991; 51: 782–6
   PubMedGoogle Scholar
• Ozawa K. Biological significance of mitochondrial redox potential in shock and multiple organ failure-redox theory. Molecular and cellular aspects of shock and trauma, A M Lefer, W Schumer. Alan R. Liss, Inc., New York 1983; 39–66
   Google Scholar
• Ozawa K, Kamiyama Y, Kimura K. Contribution of the arterial blood ketone body ratio to elevate plasma amino acids in hepatic encephalopathy of surgical patients. Am J Surg 1983; 146: 299–305
   PubMedGoogle Scholar
• Kram H B, Evans T, Bundage B. Use of dobutamine for treatment of shock liver syndrome. Crit Care Med 1988; 16: 644–5
   PubMed Web of Science ®Google Scholar
• Kurokawa T, Nonami T, Harada A. Effects of prostaglandin E1 on the recovery of ischemia-induced liver mitochondrial dysfunction in rats with cirrhosis. Scand J Gastroenterol 1991; 26: 269–74
   PubMed Web of Science ®Google Scholar
• Sinclair S B, Levy G A. Treatment of fulminant viral hepatic failure with prostaglandin E. A preliminary report. Dig Dis Sci 1991; 36: 791–800
   PubMedGoogle Scholar
• Tani T, Taki Y, Jikko A. Short-term changes in blood ketone body ratios in the phase immediately after hepatic artery embolization: their clinical significance. Am J Med Sci 1986; 291: 93–100
   PubMedGoogle Scholar
• Taki Y, Jikko A, Morimoto T. Effect of hepatic artery embolization on the adenylate energy charge level and the redox state of the cirrhotic liver. Res Exp Med 1986; 186: 179–83
   PubMedGoogle Scholar
• Moriyasu F, Ban N, Nishida O. Portal hemodynamics in patients with hepatocellular carcinoma. Radiology 1986; 161: 707–11
   PubMedGoogle Scholar
• Ozawa K, Kitamura O, Yamaoka Y. Role of portal blood on the enhancement of liver mitochondrial metabolism. Am J Surg 1972; 124: 16–20
   PubMedGoogle Scholar
• Ozawa K, Yamada T, Honjo I. Role of insulin as a portal factor in maintaining the viability of liver. Ann Surg 1974; 180: 716–9
   PubMed Web of Science ®Google Scholar
• Moreau R, Lee S S, Soupison T. Abnormal tissue oxygenation in patients with cirrhosis and liver failure. J Hepatol 1988; 7: 98–105
   PubMedGoogle Scholar
• Moreau R, Lee S S, Hadengue A. Relationship between oxygen transport and oxygen uptake in patients with cirrhosis. Effects of vasoactive drugs. Hepatology 1989; 9: 427–32
   PubMed Web of Science ®Google Scholar
• Hirai K. Histological and biochemical changes of the liver in normal dogs undergoing hepatic arterial embolization. Acta Hepatol Jpn 1983; 24: 1012–20
   Google Scholar